Stock & Company Details
Ensysce Biosciences Inc $ENSC
Price:
N/A
N/A
19M
$8.9M
52 Week High:
N/A
10 Day Average Volume:
N/A
-0.14
50 Day Moving Average:
N/A
52 Week Low:
N/A
30 Day Average Volume:
N/A
N/A
N/A
N/A
30 Day Change:
N/A
3 Month Change:
N/A
Health Technology
ENSC technical indicators
Latest Ensysce Biosciences Inc (ENSC) indicator readings as of 2026-10-09.
ENSC's 14-day RSI is 70.4, in overbought territory. At $0.53 it is trading 12.1% above its 200-day moving average of $0.47, and above its 50-day average of $0.42. Price sits above the upper Bollinger Band ($0.37 to $0.50). ADX reads 30.7, indicating a trending market.
Overview
Ensysce Biosciences Inc is a clinical-stage biotech company using its proprietary technology platforms to develop safer prescription drugs. The company is developing a new class of powerful, tamper-proof opioids that prevent both drug abuse and overdoses. Its products are anticipated to provide safer options to treat severe pain and assist in preventing deaths caused by opioid abuse, reducing human and economic costs. The company's current development pipeline includes two new drug platforms: an abuse-resistant opioid prodrug technology, the Trypsin Activated Abuse Protection, or the TAAP platform, and an over-dose protection opioid prodrug technology, the Multi-Pill Abuse Resistant, or the MPAR platform.
Finance Bot
Ask your questions
Start by typing a question below.
